| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.54 | 0.002 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |